| 期 |
标题 |
文件 |
| 卷 11, 编号 3 (2025) |
Rapid course of severe diabetic retinopathy |
|
|
Nadybina M., Ushanova F., Demidova T.
|
| 卷 11, 编号 6 (2025) |
Stress ABCDE echocardiography in patients with type 2 diabetes mellitus: integrative approach to cardiovascular risk assessment |
|
|
Safarova A., Kobalava Z., Timofeeva T., Efimova V., Abdulloev D.
|
| 卷 10, 编号 9 (2024) |
Structural and functional condition of the vascular wall in multiple sclerosis patients |
|
|
Semenyukova O., Adasheva T., Boyko A., Timofeeva N.
|
| 卷 9, 编号 5 (2023) |
Subclinical anxiety and depression in young and middle-aged persons: Occurrence, association with cardiac risk factors and multimorbidity |
|
|
Larina V., Glibko K., Arakelov S., Kasaeva D.
|
| 卷 11, 编号 7 (2025) |
Sulodexide in the treatment of lower extremities chronic venous diseases: clinical effects and evidentiary basis |
|
|
Golovanova O.
|
| 卷 9, 编号 10 (2023) |
24-hour blood pressure monitoring during treatment with free and fixed combinations of antihypertensive drugs |
|
|
Gumerov F., Mayanskaya S., Malysheva E.
|
| 卷 9, 编号 7 (2023) |
Telemedical technologies in the treatment of obesity as a way of interdisciplinary approach implementation |
|
|
Shestakova E., Lazareva A., Mazurina N., Komshilova K., Ershova E.
|
| 卷 11, 编号 8 (2025) |
Therapeutic value of pharmaceutical preparations |
|
|
Frolov M.
|
| 卷 10, 编号 2 (2024) |
Asthenia therapy: time-proven efficiency |
|
|
Frolova V.
|
| 卷 9, 编号 7 (2023) |
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease |
|
|
Tarasova L., Tsyganova Y.
|
| 卷 9, 编号 1 (2023) |
Therapy of osteoarthritis in combination with assymptomatic hyperuricemia: results of a pilot study |
|
|
Mazurov V., Bashkinov R., Inamova O., Petrova M., Morozova K.
|
| 卷 11, 编号 4 (2025) |
Triple fixed combinations therapy in patients with chronic obstructive pulmonary disease |
|
|
Karoli N., Kanaeva T.
|
| 卷 9, 编号 2 (2023) |
Course of COVID-19-associated pneumonia in patients vaccinated against COVID-19 |
|
|
Lysenko M., Poteshkina N., Ibragimova A., Krylova N., Kovalevskaya E., Karasev A., Svanadze A.
|
| 卷 11, 编号 2 (2025) |
Pulmonary embolism during pregnancy: Difficulties in diagnosis and management |
|
|
Uryasyev O., Solovieva A., Aksentyev S., Sidorova V., Miloserdov G., Nikiforova E., Cheskidov A.
|
| 卷 10, 编号 3 (2024) |
Difficulties of curation of a patient with irritable bowel syndrome |
|
|
Busalaeva E., Tarasova L.
|
| 卷 10, 编号 9 (2024) |
Difficulties of antianginal therapy selecting in an elderly polymorbid patient with coronary heart disease |
|
|
Kochetkov A., Telkova S., Dubinina A., Mironova E., Filippova T., Ostroumova O.
|
| 卷 9, 编号 3 (2023) |
Tubulointersticial nephritis |
|
|
Batyushin M., Zakusilov D., Sigitova O.
|
| 卷 10, 编号 8 (2024) |
Severe osteoporosis against primary ovarian failure in triplet sisters |
|
|
Dora S., Khalimov Y., Lisker A., Shvets Z., Volkova A., Ostroukhova E., Mamedova N., Kolyabina A.
|
| 卷 9, 编号 2 (2023) |
Dear Colleagues! |
|
|
Editorial B.
|
| 卷 9, 编号 3 (2023) |
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations |
|
|
Gaydukova I., Mazurov V., Inamova O., Tsinzerling A., Bashkinov R.
|
| 卷 10, 编号 4 (2024) |
Shock wave therapy: possibilities and perspectives for application in clinical practice for diabetic foot patients |
|
|
Teltevskaya I., Ivanova S., Yushchuk E., Mkrtumyan A., Melekhina I.
|
| 卷 9, 编号 7 (2023) |
The COPD exacerbations equation: What do we know about variables? (Literature review) |
|
|
Kostenko D.
|
| 卷 9, 编号 9 (2023) |
Levels of interleukins 1β, 23, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand in the dynamics of hypoxytherapy performing in female patients with autoimmune thyroiditis |
|
|
Ignatenko G., Maylyan E., Ignatenko T., Lesnichenko D., Valigun Y., Tumanova S.
|
| 卷 11, 编号 8 (2025) |
Ursosan in the complex treatment of patients with non-alcoholic fatty liver disease and its role in the correction of metabolic disorders (Svet study) |
|
|
Cheremukhina Y., Borovkova N., Ermilova O., Tokareva A., Kuznetsov A., Vasilkova A.
|
| 卷 9, 编号 6 (2023) |
Enhanced external counterpulsation as a measure of non-drug treatment of patients with severe and moderate ventilation disorders |
|
|
Nikolaeva N., Belenkov Y., Lishuta A., Voronkova O., Rogova E., Buyanova O., Abdullaeva G.
|
| 卷 11, 编号 7 (2025) |
Factors and mechanism of development of infectious and non-infectious pharyngitis |
|
|
Savlevich E., Markus P., Kabanova T., Yastremsky A., Kagan A., Bessonov K.
|
| 卷 10, 编号 5 (2024) |
Risk factors of brain stroke, specific for female individuals |
|
|
Maksimova M., Ayrapetova A.
|
| 卷 9, 编号 3 (2023) |
Risk factors, prevalence and rates of chronic kidney disease progression in outpatient patients with arterial hypertension |
|
|
Sigitova O., Bogdanova A., Saubanova E.
|
| 卷 11, 编号 5 (2025) |
Pharmacokinetics of indapamide in patients with arterial hypertension |
|
|
Seleznev S., Mylnikov P., Shchulkin A., Yakushin S.
|
| 卷 10, 编号 1 (2024) |
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients |
|
|
Kasimova A., Kolbin A.
|
| 卷 10, 编号 5 (2024) |
Febuxostat: efficacy and safety of the drug, prospects for application (literature review) |
|
|
Shchemeleva E., Skorodumova E.
|
| 卷 9, 编号 6 (2023) |
Federal clinical recommendations for sarcoidosis diagnosis and treatment: accents and comments |
|
|
Vizel A., Avdeev S., Malyavin A., Shmelev E., Vizel I.
|
| 卷 10, 编号 9 (2024) |
Phenomenon of aging liver. Part I: Molecular-genetic, cellular, and tissue mechanisms |
|
|
Prikhodko V., Okovityi S.
|
| 卷 11, 编号 7 (2025) |
Phenotyping of patients with arterial hypertension based on the renal filtration function and arterial stiffness using cluster analysis |
|
|
Kuchin K., Butusov M., Klemenov A.
|
| 卷 9, 编号 5 (2023) |
Phenotypical variability of cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL): Description of three cases in one family |
|
|
Grigorieva V., Nesterova V., Ruina E., Sivograk A., Averina E.
|
| 卷 10, 编号 9 (2024) |
Phenotypic clusters of patients with heart failure and ejection fraction 40% or more: A comparative observational study |
|
|
Larina V., Lunev V.
|
| 卷 11, 编号 6 (2025) |
Left ventricle remodeling phenotypes and treatment adherence in patients with heart failure after acute myocardial infarction: cluster analysis of real-life clinical data |
|
|
Fitilev S., Shkrebneva I., Klyuev D., Smirnov M.
|
| 卷 10, 编号 6 (2024) |
Atrial fibrillation: Controversial issues of modern classification, new possibilities of diagnostics and treatment |
|
|
Tarzimanova A.
|
| 卷 9, 编号 8 (2023) |
Fixed combination of levocetirizine and montelukast in the treatment of allergic rhinitis |
|
|
Bolieva L., Moulid A., Basieva A.
|
| 卷 10, 编号 3 (2024) |
Chemopreventive and anti-tumor potential of ademetionine in case of chronic hepatic disorders |
|
|
Prikhodko V., Okovityi S.
|
| 卷 9, 编号 7 (2023) |
Cholesterosis of the gallblader and clinical and diagnostical characteristics of patients with different body weight |
|
|
Girfanova L., Khlynova O.
|
| 卷 9, 编号 3 (2023) |
Chronic kidney disease in primary care practice |
|
|
Shilov E., Sigitova O.
|
| 卷 11, 编号 4 (2025) |
Chronic kidney disease in patients with arterial hypertension: frequency of its detection in real-life clinical practice |
|
|
Bilevich O., Viktorova I., Chernykh D., Bulakhova E., Shirinskaya N.
|
| 卷 9, 编号 2 (2023) |
Chronic ebv infection in clinical practice: what should be considered when diagnosing |
|
|
Nikolskiy M., Lioznov D., Malyavin A.
|
| 卷 10, 编号 6 (2024) |
Chronic night hypoxemia in patients with fibrotic interstitial lung diseases |
|
|
Obukhova A., Markov N., Zinchenko A., Rabik Y., Zaripova Z., Skvortsova R., Kulikov A.
|
| 卷 11, 编号 6 (2025) |
Chronic heart failure with supranormal left ventricular ejection fraction |
|
|
Larina V., Gavrilova A., Alekhin M.
|
| 卷 11, 编号 5 (2025) |
Chronic spontaneous (idiopathic) urticaria in combination with delayed urticaria from skin pressure |
|
|
Bolieva L.
|
| 卷 11, 编号 1 (2025) |
Chronic pancreatitis: diagnosis and treatment |
|
|
Didigova R., Evloeva D., Shadyzheva K., Malsagova K., Merzhoev L., Buzurtanova K.
|
| 卷 10, 编号 2 (2024) |
Chronic prostatitis. Clinical lecture No. 1: etiology and pathogenesis |
|
|
Borisov V.
|
| 卷 10, 编号 4 (2024) |
Chronic prostatitis. Clinical lecture No. 2: diagnostics and therapy |
|
|
Borisov V.
|
| 卷 10, 编号 6 (2024) |
Chronic prostatitis. Clinical lecture No. 3: Basic principles of treatment and prevention |
|
|
Borisov V.
|
| 卷 11, 编号 3 (2025) |
Cerebrometabolic health: cognitive impairments and methods of their correction |
|
|
Lagoda O., Antonova K., Shishkina T., Spryshkov N., Tanashyan M.
|
| 卷 10, 编号 7 (2024) |
Cytomegalovirus infection during pregnancy period |
|
|
Vasiliev V., Markin I., Rogozina N., Skripchenko N.
|
| 卷 10, 编号 4 (2024) |
Incidence degree and clinical significance of first detected hypothyroidia in patients with ST-segment elevation myocardial infarction |
|
|
Gridneva Y., Chesnikova A., Safronenko V., Edlenko E., Zatloukal M.
|
| 卷 10, 编号 1 (2024) |
What we know about gout today |
|
|
Eliseev M.
|
| 卷 11, 编号 4 (2025) |
Sensitivity and specificity of ECG criteria in the diagnosis of left atrium enlargement in patients with arterial hypertension |
|
|
Bursikov A., Abrashkina E., Galkina M.
|
| 卷 9, 编号 2 (2023) |
Expression of innate immunity TLR3 and TLR7 receptors at the level of the upper respiratory airways’ mucosa in patients with severe COVID-19 |
|
|
Abramova N., Soshchenko T., Meremyanina E., Solntseva V., Zheleznyak V., Svitich O.
|
| 卷 10, 编号 3 (2024) |
Extragastral clinical manifestations in patients with chronic atrophic gastritis |
|
|
Bakulin I., Sushilova A., Zharkov A.
|
| 卷 10, 编号 4 (2024) |
Elastic moments of arteries in patients with chronic heart failure: visceral obesity influence |
|
|
Statsenko M., Derevyanchenko M., Fabritskaya S., Shilina N.
|
| 卷 11, 编号 3 (2025) |
Electrocardiograms of patients who survived after COVID-19 |
|
|
Saifutdinov R., Saifutdinov R., Galyautdinova A., Muginova L., Mukhametzyanova N., Akramzhanov A., Akhmetzyanova Z., Galiullina G., Gilmullina R., Dzyuina V., Murakaev T., Mukhametzyanova A., Sultanova E.
|
| 卷 10, 编号 5 (2024) |
Wernicke encephalopathy of non-alcoholic genesis |
|
|
Ostapchuk E., Chikviladze S.
|
| 卷 9, 编号 7 (2023) |
Eosinophilic colitis: differential diagnosis and own observation |
|
|
Saifutdinov R., Mukhamadieva R., Dvoryankina T., Saifutdinov R., Trefilova Y., Saifutdinova T.
|
| 卷 9, 编号 10 (2023) |
Epidemiology of atherosclerotic cardiovascular diseases in some regions of the Russian Federation, clinical characteristics of patients and estimation of the efficacy of lipid-lowing therapy: study of real clinical practice |
|
|
Tuaeva I., Astakhova Z.
|
| 卷 9, 编号 10 (2023) |
Etiopathogenesis and possibilities of minimally invasive diagnostics of chronic diffuse liver diseases: literature review |
|
|
Bulatova I., Shchekotova A., Paducheva S., Gulyaeva I., Sobol A.
|
| 卷 9, 编号 3 (2023) |
Efficacy of balloon angioplasty in treatment of renal arteries fibromuscular dysplasia (10-year follow-up) |
|
|
Yakovleva E., Voloshinova E., Tyapkina M., Makhina V.
|
| 卷 9, 编号 7 (2023) |
The efficacy of inclusion of chronic atrophic gastritis and Helicobacter pylori infection screening in health survey programs |
|
|
Bakulin I., Sushilova A., Zharkov A.
|
| 卷 10, 编号 4 (2024) |
Efficacy and safety of ebastine use in patients having chronic spontaneous urticaria |
|
|
Bolieva L., Tseboeva M.
|
| 卷 11, 编号 5 (2025) |
Efficacy and tolerability of ustekinumab in patients with ulcerative colitis after failure of first-line therapy with genetically engineered biological agents |
|
|
Iakovlev A., Volkov A., Bashtovaya O.
|
| 卷 10, 编号 8 (2024) |
Efficacy of Remaxol in complex treatment of chronic viral hepatitis C |
|
|
Tarasova L., Tsyganova Y.
|
| 卷 10, 编号 3 (2024) |
Efficacy of use of Enerion (sulbuthiamine) in asthenia treatment in patients having chronic non-infectious diseases in outpatient practice |
|
|
Shimokhina N., Petrova M., Bychkovskaya M.
|
| 501 - 570 的 570 信息 |
<< < 1 2 3 4 5 6 |
